CIK 0001820190
- Emerging growth company
Scilex Holding Co
Sign in to watch- Ticker
- SCLX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-516-4310
- Business address
- 960 SAN ANTONIO ROAD, PALO ALTO, CA, 94303
- Former names
- Scilex Holding Company/DE, Vickers Vantage Corp. I
Securities
- SCLX Common Stock Nasdaq
- SCLXW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-08 | Followwill Dorman Director | Grant or award · Nonstatutory Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2024-12-16 | Followwill Dorman Director | Grant or award · Nonstatutory Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2024-10-18 | Followwill Dorman Director | Purchase | +1,000 | $0.99 | $990 | 2,300 |
| 2024-06-26 | Followwill Dorman Director | Option exercise | +1,000 | $1.37 | $1K | 1,300 |
| 2024-06-26 | Followwill Dorman Director | Option exercise · Nonstatutory Stock Option (right to buy) | −1,000 | 99,000 | ||
| 2024-03-15 | Followwill Dorman Director | Grant or award · Nonstatutory Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2023-01-17 | Followwill Dorman Director | Grant or award · Nonstatutory Stock Option (right to buy) | +250,000 | 250,000 |
Page 1 of 1 · 7 trades